On Monday, Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s shares inclined 3.32% to $13.06.
Amicus Therapeutics, Inc. (FOLD) a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has strengthened its executive leadership with the appointment of two new senior members of the commercial and executive team. Mark Baldry, a biopharmaceutical brand strategist with senior-level experience at Biogen Inc. and Shire plc, has joined the Company as Vice President of Global Marketing. Willem van Weperen, most recently the former Chief Commercial Officer of Prosensa Holding N.V., has been designated Regional Vice President and Country Manager, International. Both Messrs. Baldry and van Weperen held the positions of Global Head of Marketing for Rare Diseases at Shire and Genzyme, respectively. Additionally, Hung Do, Ph.D. has been promoted to Chief Science Officer.
Mark Baldry - Vice President of Global Marketing
Mr. Baldry has more than 25 years experience in the life science industry and joins Amicus from Biogen Inc., where he most recently served as Vice President, Public Affairs and formerly as Vice President, New Product Commercialization.
Willem van Weperen - Regional Vice President and Country Manager, International
Mr. van Weperen has more than 20 years of experience and most served as Chief Commercial Officer of Prosensa Holding N.V. (attained by BioMarin). Formerly, he was Head of Global Marketing in the rare genetic disease business unit at Genzyme and General Manager of Genzyme Netherlands. Mr. van Weperen will be responsible for managing the commercial launch of Galafold for Fabry disease in the Netherlands, Belgium and several Central & Eastern European countries, in addition to Middle East, Africa, Asia Pacific and Latin America.
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease.
Prologis Inc (NYSE:PLD)’s shares dropped -0.45% to $39.80.
Prologis, Inc. (PLD), the global leader in industrial real estate, declared that Thomas S. Olinger, chief financial officer; Michael S. Curless, chief investment officer; and Gary Anderson, CEO, Europe and Asia, are planned to take part in REITWeek 2015: NAREIT’s Investor Forum at the Waldorf Astoria in New York City.
Prologis is planned to present on Tuesday, June 9, at 4:30 p.m. ET/1:30 p.m. PT.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, administration, and leasing of industrial distribution and retail properties. It was formerly known as Security Capital Investment Trust. Prologis Inc. was formed in 1991 and is based in San Francisco, California with an additional office in Denver, Colorado.
At the end of Monday’s trade, Pier 1 Imports Inc (NYSE:PIR)‘s shares surged 1.16% to $12.21.
Pier 1 Imports Inc (PIR) issued a press release announcing that it will distribute its first quarter fiscal 2016 financial results after market close on Wednesday, June 17, 2015, followed by a conference call at 3:30 p.m. Central Time. The call will be hosted by Alex Smith, President and Chief Executive Officer, and Laura Coffey, Executive Vice President and Interim Chief Financial Officer. A copy of this press release is attached hereto as Exhibit 99.1.
Moreover company declared that it will distribute its first quarter fiscal 2016 financial results after market close on Wednesday, June 17, 2015, followed by a conference call at 3:30 p.m. Central Time. The call will be hosted by Alex Smith, President and Chief Executive Officer, and Laura Coffey, Executive Vice President and Interim Chief Financial Officer.
Pier 1 Imports, Inc. engages in the retail sale of decorative home furnishings, furniture, gifts, and related items. The company offers decorative accents and textiles, such as rugs, wall decorations and mirrors, pillows, bedding, lamps, vases, dried and artificial flowers, baskets, ceramics, dinnerware, candles, fragrance, gift, and seasonal items.
E*TRADE Financial Corp (NASDAQ:ETFC), ended its Monday’s trading session with -0.46% loss, and closed at $30.53.
E*TRADE Financial Corp (ETFC) declared it topped $50 billion in retirement assets under administration as of the end of May 2015. Retirement assets have more than doubled since May 2010 — up from $24 billion — as investors increasingly turn to E*TRADE to take control of their retirement, investing, and savings.
In the first quarter of this year, roughly one-fourth of net new assets were in retirement accounts. Assets in managed accounts reached $3.2 billion in Q1 2015, up an impressive 24 percent from a year ago.
E*TRADE is a partner in assisting investors balance needs with tomorrow’s aims through pioneering digital tools and personalized, smart guidance, both online and from nearly 300 seasoned financial consultants on the phone or in-person at our branches throughout the U.S. Investors have access to E*TRADE’s Online Portfolio Advisor, comprehensive Education Center, and OneStop IRA Rollover, just to name a few. To learn more about how E*TRADE assists investors make retirement easier, visit etrade.com/retirement.
E*TRADE Financial Corporation, a financial services company, provides brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand name. It operates through two segments, Trading and Investing, and Balance Sheet Administration.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
